Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors
ChemMedChem · 2026-01 · 21 (2)
DOI: 10.1002/cmdc.202501008 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 31.01.2026. Verfasst von Zhenzhen Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Pharmaceutical Research Institute, Taizhou Vocational & Technical College, No. 788, Xueyuan Road, Jiaojiang District, Taizhou, 318000, P. R.…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Molecular Docking Simulation, Antineoplastic Agents, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Science and Technology Plan Project of Taizhou, General Research Projects of Taizhou Vocational and Technical College.
Abstract (Originalsprache)
Two series of [1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine derivatives have been synthesized and evaluated for their antitumor activities. These compounds exhibit potent antiproliferative activities against A549 and H460 cells and c‐Met kinase inhibitory activities. Five compounds are highly effective against A549 and H460 cells with IC 50 values in 2.97–16.50 μM (the mean ± SD value of three independent determinations). Molecular docking is further performed to study the inhibitor–c‐Met kinase interactions, and the results show that compound 3a is potently bound to the c‐Met kinase with three hydrogen bonds, one π‐‐‐π, and one CH‐‐‐π interactions. Based on the preliminary results, it is deduced that compound 3a with potent c‐Met kinase inhibitory activity may be a potential anticancer agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Pharmaceutical Research Institute, Taizhou Vocational & Technical College, No. 788, Xueyuan Road, Jiaojiang District, Taizhou, 318000, P. R. China.
- Research Institute, Zhejiang Haizhou Pharmaceutical Co. Ltd., No. 19, Donghai Fifth Avenue, Linhai City, Taizhou, 318000, P. R. China.
- Research Institute, Zhejiang Hongyuan Pharmaceutical Co. Ltd., No. 6, Donghai Fourth Avenue, Linhai City, Taizhou, 318000, P. R. China.
ORCID-Profile: Feng Xu
Förderung
- Science and Technology Plan Project of Taizhou
- General Research Projects of Taizhou Vocational and Technical College
Zitieren
APA
Yang, Z., Xu, F., Wang, G., Ran, Y., Wang, J., Teng, J., Lv, Y., Fang, Z., Ye, Y., Ye, X., Zhou, Y., Yang, W., & Yan, J. (2026). Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors. ChemMedChem, 21(2). https://doi.org/10.1002/cmdc.202501008
Vancouver
Yang Z, Xu F, Wang G, Ran Y, Wang J, Teng J, et al. Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors. ChemMedChem. 2026;21(2). doi:10.1002/cmdc.202501008
BibTeX
@article{Yang2026,
author = {Yang, Zhenzhen and Xu, Feng and Wang, Guan and Ran, Yan and Wang, Jian and Teng, Jiaxin and Lv, Yanghong and Fang, Zhelin and Ye, Yutong and Ye, Xinkai and Zhou, Yijing and Yang, Weiqiang and Yan, Jianbo},
title = {Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {2},
doi = {10.1002/cmdc.202501008}
}
EUVIMED